Clinical Trials · NCT03158805
Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Lindner Center of HOPE
- Enrollment
- 60
- Start date
- Apr 2017
- Locations
- 1 site, United States
- Primary endpoint
- Percent Change in Body Weight